Page last updated: 2024-11-05

zardaverine and Eosinophilia

zardaverine has been researched along with Eosinophilia in 1 studies

zardaverine: structure given in first source
zardaverine : A pyridazinone derivative in which pyridazin-3(2H)-one is substituted at C-6 with a 4-(difluoromethoxy)-3-methoxyphenyl group. It is a phosphodiesterase inhibitor, selective for PDE3 and 4.

Eosinophilia: Abnormal increase of EOSINOPHILS in the blood, tissues or organs.

Research Excerpts

ExcerptRelevanceReference
"Zardaverine is shown to inhibit selectively two out of five isoenzyme classes of phosphodiesterases, namely PDE III from human platelets and PDE IV from human polymorphonuclear leucocytes (PMN) with IC50 values of 0."2.38Zardaverine: a cyclic AMP specific PDE III/IV inhibitor. ( Beume, R; Eltze, M; Kilian, U; Schudt, C; Winder, S, 1991)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schudt, C1
Winder, S1
Eltze, M1
Kilian, U1
Beume, R1

Reviews

1 review available for zardaverine and Eosinophilia

ArticleYear
Zardaverine: a cyclic AMP specific PDE III/IV inhibitor.
    Agents and actions. Supplements, 1991, Volume: 34

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Allergens; Animals; Bronchial Diseases; Eosinophilia; Humans; I

1991